Journal
JOURNAL OF DAIRY SCIENCE
Volume 95, Issue 4, Pages 1921-1929Publisher
ELSEVIER SCIENCE INC
DOI: 10.3168/jds.2011-5065
Keywords
antimicrobial resistance; antimicrobial use; mastitis; Staphylococcus aureus
Funding
- Natural Science and Engineering Research Council of Canada (Ottawa, ON, Canada)
- Alberta Milk (Edmonton, AB, Canada)
- Dairy Farmers of New Brunswick, Nova Scotia, Ontario and Prince Edward Island
- Novalait Inc. (Quebec, QC, Canada)
- Dairy Farmers of Canada (Ottawa, ON, Canada)
- Canadian Dairy Network (Guelph, ON, Canada)
- Agriculture and Agri-Food Canada (Ottawa, ON, Canada)
- Public Health Agency of Canada (Ottawa, ON, Canada)
- Technology PEI Inc. (Charlottetown, PEI, Canada)
- Universite de Montreal (Montreal, QC, Canada)
- University of Prince Edward Island (Charlottetown, PEI, Canada), through the Canadian Bovine Mastitis Research Network
Ask authors/readers for more resources
Surveillance of antimicrobial use and resistance is needed to manage antimicrobial resistance in bacteria. In this study, data were collected on antimicrobial use and resistance in Staphylococcus aureus (n = 562), isolated from intramammary infections and (sub)clinical mastitis cases on 89 dairy farms in 4 regions of Canada [Alberta, Ontario, Quebec, and the Maritime Provinces (Prince Edward Island, Nova Scotia, and New Brunswick)]. Dairy producers were asked to deposit empty drug containers into specially provided receptacles, and antimicrobial drug use rate was calculated to quantify antimicrobial use. Minimum inhibitory concentrations were determined using the Sensititer bovine mastitis plate system (TREK Diagnostic Systems Inc., Cleveland, OH), containing antimicrobials commonly used for mastitis treatment and control. Multivariable logistic regression models were built to determine herd-level risk factors of penicillin, ampicillin, pirlimycin, penicillin-novobiocin combination, tetracycline and sulfadimethoxine resistance in Staph. aureus isolates. Intramammary administration of the penicillin-novobiocin combination for dry cow therapy was associated with penicillin and ampicillin resistance [odds ratio (OR): 2.17 and 3.10, respectively]. Systemic administration of penicillin was associated with penicillin resistance (OR: 1.63). Intramammary administration of pirlimycin for lactating cow mastitis treatment was associated with pirlimycin resistance as well (OR: 2.07). Average herd parity was associated with ampicillin and tetracycline resistance (OR: 3.88 and 0.02, respectively). Average herd size was also associated with tetracycline resistance (OR: 1.02). Dairy herds in the Maritime region had higher odds of penicillin and lower odds of ampicillin resistance than dairy herds in Quebec (OR: 2.18 and 0.19, respectively). Alberta dairy herds had lower odds of ampicillin and sulfadimethoxine resistance than dairy herds in Quebec (OR: 0.04 and 0.08, respectively). Ontario dairy herds had lower odds of tetracycline and sulfadimethoxine resistance than dairy herds in Quebec (OR: 0.05 and 0.33, respectively). Herd-level use of certain antimicrobials administered for mastitis treatment and control, such as intramammary penicillin and pirlimycin as well as systemically administered penicillin and florfenicol, was positively associated with antimicrobial resistance in bovine mastitis pathogens in the field conditions. Differences in antimicrobial resistance outcomes across 4 regions of Canada were observed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available